Information on attributable items

As part of the change in attributable items to 2025, indication restrictions have been introduced for medicines that are listed in the Categorised List of Medicines. For discharged patients from 2024, in order to maintain continuity of their treatment, attributable items can continue to be reported when treatment is continued, even if they do not comply with the indication restrictions.